In vitro studies have demonstrated that PUP treatment effectively downregulated immunosuppression in tumor cells, as evidenced by a significant reduction in transforming growth factor beta 1 (TGF-β1) levels in rectal cancer-derived Colon26 cells. Here, TGFB1 is linked to rectal cancer.